“Feasible and effective administration of Bortezomib with Rituximab in children with relapsed/resistant B-cell precursor acute lymphoblastic leukemia (BCP-ALL): A step toward the first line”

.

Source: Pediatric Hematology and Oncology - September 13, 2019 Category: Pediatrics Authors: Luca Lo Nigro Giulio Pulvirenti Emanuela Cannata Paola Bonaccorso Nellina Andriano Giovanna Russo Source Type: research